Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001 von Shaw, A.T., Riely, G.J., Bang, Y.-J., Kim, D.-W., Camidge, D.R., Solomon, B.J., Varella-Garcia, M., Iafrate, A.J., Shapiro, G.I., Usari, T., Wang, S.C., Wilner, K.D., Clark, J.W., Ou, S.-H.I.

Volltext

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC von Ou, S.-H. I., Jänne, P.A., Bartlett, C.H., Tang, Y., Kim, D.-W., Otterson, G.A., Crinò, L., Selaru, P., Cohen, D.P., Clark, J.W., Riely, G.J.

Volltext

Efficacy and Safety of Axitinib in Patients With Advanced Non–Small-Cell Lung Cancer: Results From a Phase II Study von SCHILLER, Joan H, LARSON, Timothy, VON PAWEL, Joachim, IGNATIUS OU, S.-H, LIMENTANI, Steven, SANDLER, Alan, VOKES, Everett, KIM, Sinil, LIAU, Katherine, BYCOTT, Paul, OLSZANSKI, Anthony J

Volltext

Prognostic factors for survival of stage I nonsmall cell lung cancer patients : A population-based analysis of 19,702 stage I patients in the California cancer registry from 1989 t... von OU, S.-H. Ignatius, ZELL, Jason A, ZIOGAS, Argyrios, ANTON-CULVER, Hoda

Volltext

Low socioeconomic status is a poor prognostic factor for survival in stage I nonsmall cell lung cancer and is independent of surgical treatment, race, and marital status von Ou, S.‐H. Ignatius, Zell, Jason A., Ziogas, Argyrios, Anton‐Culver, Hoda

Volltext

Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology von Ou, S.-H.I, Zell, J.A., Ziogas, A., Anton-Culver, H.

Volltext

The allure of ‘ALUR’ von Nagasaka, M., Zhu, V.W., Ou, S.-H.I.

Volltext

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma von Kim, H.R., Lim, S.M., Kim, H.J., Hwang, S.K., Park, J.K., Shin, E., Bae, M.K., Ou, S.-H.I., Wang, J., Jewell, S.S., Kang, D.R., Soo, R.A., Haack, H., Kim, J.H., Shim, H.S., Cho, B.C.

Volltext

Epidemiology of Bronchioloalveolar Carcinoma: Improvement in Survival After Release of the 1999 WHO Classification of Lung Tumors von ZELL, Jason A, IGNATIUS OU, S.-H, ZIOGAS, Argynos, ANTON-CULVER, Hoda

Volltext

Spectral wave modelling of Typhoon Krosa von Babanin, A. V., Hsu, T.-W., Roland, A., Ou, S.-H., Doong, D.-J., Kao, C. C.

Volltext

Natural history of stage I Non-Small cell lung cancer : Implications for early detection von RAZ, Dan J, ZELL, Jason A, IGNATIUS OU, S-H, CANDARA, David R, ANTON-CULVER, Hoda, JABLONS, David M

Volltext

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study von Mok, T., Camidge, D.R., Gadgeel, S.M., Rosell, R., Dziadziuszko, R., Kim, D.-W., Pérol, M., Ou, S.-H.I., Ahn, J.S., Shaw, A.T., Bordogna, W., Smoljanović, V., Hilton, M., Ruf, T., Noé, J., Peters, S.

Volltext

190TiP ELUXA 1: Phase II study of BI 1482694 (HM61713) in patients (pts) with T790M-positive non-small cell lung cancer (NSCLC) after treatment with an epidermal growth factor rece... von Park, K., Han, J.-Y., Kim, D.-W., Bazhenova, L.A., Ou, S.-H., Pang, Y.-K., Hin, H.S., Juan, O., Son, J., Jänne, P.

Volltext

Nonlinear run-ups of regular waves on sloping structures von Hsu, T.-W, Liang, S.-J, Young, B.-D, Ou, S.-H

Volltext

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer von Lin, J.J., Liu, S.V., McCoach, C.E., Zhu, V.W., Tan, A.C., Yoda, S., Peterson, J., Do, A., Prutisto-Chang, K., Dagogo-Jack, I., Sequist, L.V., Wirth, L.J., Lennerz, J.K., Hata, A.N., Mino-Kenudson, M., Nardi, V., Ou, S.-H.I., Tan, D.S.-W., Gainor, J.F.

Volltext

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC) von Drilon, A., Li, G., Dogan, S., Gounder, M., Shen, R., Arcila, M., Wang, L., Hyman, D.M., Hechtman, J., Wei, G., Cam, N.R., Christiansen, J., Luo, D., Maneval, E.C., Bauer, T., Patel, M., Liu, S.V., Ou, S.H.I., Farago, A., Shaw, A., Shoemaker, R.F., Lim, J., Hornby, Z., Multani, P., Ladanyi, M., Berger, M., Katabi, N., Ghossein, R., Ho, A.L.

Volltext

Innovative personalized medicine in gastric cancer: time to move forward von Lee, J., Kim, K.-M., Kang, W.K., Ou, S.-H.I.

Volltext

Validation of the Proposed International Association for the Study of Lung Cancer Non-small Cell Lung Cancer Staging System Revisions for Advanced Bronchioloalveolar Carcinoma Usin... von Zell, Jason A., Ignatius Ou, S -H., Ziogas, Argyrios, Anton-Culver, Hoda

Volltext

Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis von Zell, J. A., Ou, S.-H. I., Ziogas, A., Anton-Culver, H.

Volltext

Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib von Oztan, A., Fischer, S., Schrock, A.B., Erlich, R.L., Lovly, C.M., Stephens, P.J., Ross, J.S., Miller, V., Ali, S.M., Ou, S.-H.I., Raez, L.E.

Volltext